PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients

Triple-negative breast cancer (TNBC) constitutes a heterogeneous breast cancer subgroup with poor prognosis; survival rates are likely to be lower with TNBC compared to other breast cancer subgroups. For this disease, systemic adjuvant chemotherapy regimens often yield suboptimal clinical results. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Absmaier, Magdalena, Napieralski, Rudolf, Schuster, Tibor, Aubele, Michaela, Walch, Axel, Magdolen, Viktor, Dorn, Julia, Gross, Eva, Harbeck, Nadia, Noske, Aurelia, Kiechle, Marion, Schmitt, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807037/
https://www.ncbi.nlm.nih.gov/pubmed/29328369
http://dx.doi.org/10.3892/ijo.2018.4241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807037/
https://www.ncbi.nlm.nih.gov/pubmed/29328369
http://dx.doi.org/10.3892/ijo.2018.4241

Ejemplares similares